Artelo Biosciences Inc (ARTL)
US$ 1.33-3.62%
Price Chart
Key Statistics
Market Cap
$ 6.95M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
34.18K
52W High
$ 28.60
52W Low
$ 4.92
Dividend Yield
0.00%
Beta
1.36
Technicals
50-Day MA
10.5882
200-Day MA
7.5149
52 Week High
28.6
52 Week Low
4.9176
About ARTL
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.
Employees
5
Headquarters
Solana Beach, CA
CEO
Mr. Gregory D. Gorgas M.B.A.